Novo Nordisk is sponsoring an educational program to be developed in 2005 by the University of Pittsburgh School of Pharmacy. As a world leader in diabetes care, the company will provide an unrestricted educational grant of $500,000 for the pharmacy school to underwrite the program.
The educational program, entitled "An Elective Course in Comprehensive Diabetes Management," will be developed over several months with advice from a panel of experts in diabetes management, pharmacy education, and instructional development. The panel will set up teams of educators to instruct the trainers who will teach the course. Pharmacy schools also will be invited to send faculty members to the regional training sessions.
Schools using the program will receive instructional materials. The schools will be encouraged to work together by sharing teaching techniques, new course materials, and assessment methods. Once the initiative moves into the implementation phase, the panel will evaluate how the course is used by pharmacy schools, get student and instructor course assessments, and revise the course as necessary.